Insider · CIK 0001290907
Christopher R Reidy
director
Files at EHC (Encompass Health Corp), EMBC (Embecta Corp.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +17 | $0.00 | $0 | 14,448 | Jul 16, 2025 |
| Jul 16, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +333 | $106.89 | $36k | 14,781 | Jul 16, 2025 |
| May 1, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +1,424 | $0.00 | $0 | 14,431 | May 2, 2025 |
| Apr 22, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +360 | $98.23 | $35k | 13,007 | Apr 23, 2025 |
| Apr 15, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +15 | $0.00 | $0 | 12,647 | Apr 16, 2025 |
| Feb 12, 2025 | EMBC Embecta Corp. | AGrant or award Common Stock | +13,839 | $0.00 | $0 | 45,284 | Feb 14, 2025 |
| Jan 15, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +16 | $0.00 | $0 | 12,257 | Jan 17, 2025 |
| Jan 16, 2025 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +375 | $94.38 | $35k | 12,632 | Jan 17, 2025 |
| Oct 15, 2024 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +16 | $0.00 | $0 | 11,879 | Oct 17, 2024 |
| Oct 17, 2024 | EHC Encompass Health Corp | AGrant or award Encompass Health Common Stock | +362 | $97.53 | $35k | 12,241 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.